153 related articles for article (PubMed ID: 21293543)
1. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543
[TBL] [Abstract][Full Text] [Related]
2. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
Li MW; Niu CS
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
[TBL] [Abstract][Full Text] [Related]
3. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
[TBL] [Abstract][Full Text] [Related]
4. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
5. What is the clinical value of cancer stem cell markers in gliomas?
Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
[TBL] [Abstract][Full Text] [Related]
6. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
Sabet MN; Rakhshan A; Erfani E; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
[TBL] [Abstract][Full Text] [Related]
9. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
11. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
[TBL] [Abstract][Full Text] [Related]
12. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CD133 and Notch1 in non-small cell lung cancer and the clinicopathological significance].
Zhou L; Wu S; Yu L; Gong X; Song W; Cheng Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):196-201. PubMed ID: 25736112
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
Roudi R; Korourian A; Shariftabrizi A; Madjd Z
Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
[TBL] [Abstract][Full Text] [Related]
15. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
[TBL] [Abstract][Full Text] [Related]
16. The pathological characteristics of glioma stem cell niches.
He H; Li MW; Niu CS
J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
[TBL] [Abstract][Full Text] [Related]
17. CD133 identifies perivascular niches in grade II-IV astrocytomas.
Christensen K; Schrøder HD; Kristensen BW
J Neurooncol; 2008 Nov; 90(2):157-70. PubMed ID: 18612800
[TBL] [Abstract][Full Text] [Related]
18. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
[TBL] [Abstract][Full Text] [Related]
19. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms.
Schittenhelm J; Simon P; Harter PN; Zachskorn C; Schlaszus H; Röttger F; Winkels M; Weller M; Meyermann R; Mittelbronn M
Histopathology; 2011 Apr; 58(5):739-49. PubMed ID: 21438906
[TBL] [Abstract][Full Text] [Related]
20. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
